Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: The Prostate, 82, 14, S. 1406-1412

Ereignis
Veröffentlichung
(wo)
Augsburg
(wer)
Universität Augsburg
(wann)
2022
Ereignis
Veröffentlichung
(wo)
Hoboken
(wer)
Wiley
(wann)
2022
Urheber
Hartrampf, Philipp E.
Weinzierl, Franz‐Xaver
Seitz, Anna Katharina
Kübler, Hubert
Essler, Markus
Buck, Andreas K.
Wolf, Herta
Bundschuh, Ralph A.

DOI
10.1002/pros.24414
URN
urn:nbn:de:bvb:384-opus4-975225
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:48 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Hartrampf, Philipp E.
  • Weinzierl, Franz‐Xaver
  • Seitz, Anna Katharina
  • Kübler, Hubert
  • Essler, Markus
  • Buck, Andreas K.
  • Wolf, Herta
  • Bundschuh, Ralph A.
  • Universität Augsburg
  • Wiley

Entstanden

  • 2022

Ähnliche Objekte (12)

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity

Some Analytical Considerations on the Measurement of Prostate-Specific Antigen

Some Analytical Considerations on the Measurement of Prostate-Specific Antigen

Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy

Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy

Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen

Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen

Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer

Hochschulschrift

Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer

Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy

Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer

Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy

Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy

Development of inhibitors of the prostate specific membrane antigen (PSMA) for imaging and endoradiotherapy

Development of inhibitors of the prostate specific membrane antigen (PSMA) for imaging and endoradiotherapy

Top-Down Fabricated Silicon Nanowire Arrays for Field-Effect Detection of Prostate-Specific Antigen

Top-Down Fabricated Silicon Nanowire Arrays for Field-Effect Detection of Prostate-Specific Antigen

Radiochemistry and preclinical PET imaging of 68Ga-desferrioxamine radiotracers targeting prostate-specific membrane antigen

Radiochemistry and preclinical PET imaging of 68Ga-desferrioxamine radiotracers targeting prostate-specific membrane antigen

Verbundene Objekte